What’s Next? The Road to 2035

As we look toward 2035, experts anticipate major breakthroughs in the safety, scalability, and availability of regrown organs.
The pace of clinical adoption will accelerate as technologies mature, regulatory pathways become clearer, and costs decrease.
By then, organ regeneration could be a routine part of medical care, reshaping global healthcare and giving millions of patients a new lease on life.